Horizon Therapeutics USA, Inc. – FDA Inspection, May 25, 2023

Record Details

This FDA Inspection record concerns Horizon Therapeutics USA, Inc., with an inspection on May 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Horizon Therapeutics USA, Inc.
Inspection Date: May 25, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Carolyn A. Volpe (Issuing Officer)
Jeanne J. Thai (Company Rep)

View Company Profile

ID · 234127af-3893-4edd-9682-b97f2e8c7bea

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1209517
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Horizon Therapeutics USA, Inc.

FDA Inspection

Horizon Therapeutics USA, Inc.May 25, 2023